We are live on ! Find out more
CRVO icon

CervoMed
CRVO

18 hedge funds and large institutions have $1.59M invested in CervoMed in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

600% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 1

500% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 1

50% more funds holding

Funds holding: 12 → 18 (+6)

27% more capital invested

Capital invested by funds: $1.25M → $1.59M (+$342K)

0.05% less ownership

Funds ownership: 0.19% → 0.14% (-0.05%)

Holders
18
Holders Change
+6
Holders Change %
+50%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
6
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$669K
2
Renaissance Technologies
Renaissance Technologies
New York
+$549K
3
SM
Sabby Management
Florida
+$503K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$196K
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$188K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$37.3K
2
Morgan Stanley
Morgan Stanley
New York
-$795
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$500K +$503K +8,235 +132%
BlackRock
2
BlackRock
New York
$378K +$669K +10,944 New
Renaissance Technologies
3
Renaissance Technologies
New York
$349K +$549K +8,985 +798%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$115K +$196K +3,215 +2,399%
Acadian Asset Management
5
Acadian Asset Management
Massachusetts
$114K +$188K +3,084 +1,359%
Barclays
6
Barclays
United Kingdom
$71K +$125K +2,046 New
UBS Group
7
UBS Group
Switzerland
$19K +$29.7K +486 +675%
Vanguard Group
8
Vanguard Group
Pennsylvania
$13K -$37.3K -610 -63%
Creative Planning
9
Creative Planning
Kansas
$9K +$16.4K +269 New
SRCM
10
Swift Run Capital Management
Virginia
$7K – – –
FAN
11
Financial Advisors Network
California
$5K +$8.13K +133 New
PAG
12
Private Advisor Group
New Jersey
$5K +$8.98K +147 New
SWM
13
Sugarloaf Wealth Management
Georgia
$2K +$2.87K +47 New
Wells Fargo
14
Wells Fargo
California
$2K +$4.09K +67 New
Bank of America
15
Bank of America
North Carolina
$2K +$4.34K +71 +7,100%
Morgan Stanley
16
Morgan Stanley
New York
– -$795 -13 Closed

CRVO Hedge Fund Activity: Q4 2019 in Review

18 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q4 2019, worth a combined $1.59M — up 27% from $1.25M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new CRVO positions and 1 closed out — a net gain of 6 holders — while 6 added to existing stakes and 1 trimmed.

The largest buyer was BlackRock, opening a new position worth an estimated $669K. The largest seller was Vanguard Group, cutting an estimated $37.3K.

  • 18 institutional investors held CervoMed (CRVO) as of Q4 2019, up from 12 in Q3 2019.
  • Funds reported $1.59M of CervoMed stock for Q4 2019, up 27% quarter-over-quarter.
  • 7 funds opened new CervoMed positions in Q4 2019 and 1 closed out, a net change of +6 holders.
  • The largest CervoMed buyer in Q4 2019 was BlackRock, an estimated $669K added.
  • The largest CervoMed seller in Q4 2019 was Vanguard Group, an estimated $37.3K sold.

Based on aggregated 13F filings for Q4 2019.